(PINKSHEETS: APGR), (OTCBB: PAYD), (OTCBB: AEMD), (OTCBB: ARDM).

RealPennies.com: Turning Pennies into dollars: (PINKSHEETS: APGR), (OTCBB: PAYD), (OTCBB: AEMD), (OTCBB: ARDM).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://apgr.realpennies.com

Alpine TLI Group, Inc. (PINKSHEETS: APGR)(January 16, 2008), a full service tax lien and tax deed purchase, research, and property management company, announced earlier today that it has registered to participate in Arizona's Maricopa County tax sale. This sale will begin on Jan. 17th and continue through Feb. 1st. Historically, Maricopa has offered over 20,000 tax liens for sale with a total property value of over $2 Billion. Maricopa offers many opportunities for Alpine to pick up liens on property for as little as 1% of the property value.

M. Taylor Abegg, II, Chief Executive Officer of Alpine TLI Group, Inc., stated, "We are excited to participate in the first big tax sale of the year. Alpine will not only have more than $2 Billion in property to choose from but the tax sale in Maricopa County offers some unique opportunities for experienced investors, such as Alpine. One major benefit will be the reduced acquisition costs associated with this sale. Maricopa County's tax sale is online which allows Alpine to bid on property tax liens without incurring the cost of placing representatives onsite to participate in the sale. We look forward with great anticipation to the results of Maricopa's sale."

ALPINE TLI GROUP, Inc. is a full service tax lien and tax deed purchase, research, and property management company. Alpine specializes in identifying and researching properties that have the propensity of creating a highly leveraged investment opportunity through the purchase of real estate tax lien certificates and tax deeds.

It is estimated that over $10 Billion in property tax liens are offered for sale annually representing over $1 Trillion in potential property value profits for the purchasers of these tax liens. Tax lien certificates are typically acquired by Alpine for 1% to 20% of the property value. If the lien is redeemed by the property owner, a return of 4% to 25% APR is realized by Alpine. If the lien is not redeemed, the deed to the property is granted to Alpine, free and clear of all encumbrances. More information on Alpine TLI Group is available online at http://www.AlpineTLIGroup.com/.

For more info: http://payd.realpennies.com

EFI, the world leader in customer-focused digital printing innovation, and Paid, Inc. (OTCBB: PAYD) (January 16, 2008) announced earlier today that the two companies have signed a license agreement that enables EFI to integrate Paid's real-time online shipping calculation technology into its PrinterSite order system via an application protocol interface (API). The licensing agreement with EFI marks the first API integration since the United States Patent and Trademark Office issued the patent for portions of Paid's online shipping calculation technology in January 2008. Under the annual renewable contract, EFI will pay Paid, Inc. an annual licensing fee that will allow EFI's system to access Paid's AuctionInc server to calculate or recalculate shipping costs in real time for customer orders. The shipping calculation API is now live on the PrinterSite order system.

For EFI, and for eCommerce companies in general, shopping cart abandonment is a problem that they are seeking to solve. According to Practical eCommerce, "Seventy-two percent of shoppers cite shipping as a top reason for shopping cart abandonment." With estimates in Shop.org and Forrester Research's "State of Retailing Online 2007" study that online retail sales, excluding travel, were $146.5 billion in 2006 and were projected to grow to $174.5 billion for 2007, few companies want to risk losing shoppers once they have lured them to their sites. Additionally, a groundbreaking research study by Jupiter analyst Ken Cassar revealed that the largest percentage of ecommerce customers believe that shipping and handling charges should be a function of product weight.

The online shipping calculation technology enables EFI to automatically calculate multiple carrier shipping, packaging, insurance and handling costs for orders placed through its clients' web sites as each item is added to the shopping cart, eliminating the surprise of true shipping costs at check-out. EFI also plans to have its call center operators use the API to calculate shipping charges for phone orders in order to provide customers with total order cost instantly.

EFI (www.efi.com) is the world leader in customer-focused digital printing innovation. EFI's award-winning solutions, integrated from creation to print, deliver increased performance, cost savings and productivity. The company's robust product portfolio includes Fiery digital color print servers; VUTEk superwide digital inkjet printers, UV and solvent inks; Jetrion industrial inkjet printing systems; print production workflow and management information software; and corporate printing solutions. EFI maintains 23 offices worldwide.

EFI, Fiery, VUTEk and Jetrion are registered trademarks of Electronics For Imaging, Inc. in the U.S. Patent and Trademark Office and/or certain other foreign jurisdictions. All other trademarks mentioned in this document are the property of their respective owners.

Paid, Inc. operates a diversified set of businesses, including its celebrity services and AuctionInc ecommerce technology businesses. Using proprietary patent-pending technology, Paid's innovative AuctionInc brand shipping calculation and auction management software and services are utilized to streamline online auctions, ecommerce and web site development and hosting. Paid, Inc.'s celebrity services provides celebrities and organizations with official Web sites and fan club services that include e-commerce storefronts, ticketing and fan experience packages and web site content to attract tens of thousands of visitors daily, as detailed on its web site, www.paidcelebrity.com. The Company also sponsors autograph signing events and other sports marketing services for sports clientele. The Company's common stock is traded on the OTC Bulletin Board under the symbol PAYD. For further information, visit http://www.paid.com.

For more info: http://aemd.realpennies.com

Aethlon Medical, Inc., (OTCBB: AEMD)(January 16, 2008) a pioneer in developing therapeutic devices for infectious disease, disclosed earlier today that its Hemopurifier treatment technology is featured in the January 2008 edition of "Medical Breakthroughs", a television series produced by Ivanhoe Broadcast News. Ivanhoe Broadcast News is a leading newsgathering organization covering advances in the medical field. The "Medical Breakthroughs" series is broadcast in 250 markets reaching up to 80 million U.S. households. Video coverage of the story is available to be accessed at: www.aethlonmedical.com/news/inthenews.htm

Aethlon Medical is the developer of the Hemopurifier , a first-in-class medical device to treat infectious disease. The Hemopurifier addresses the largest opportunity in infectious disease, the treatment of drug and vaccine resistant viruses. The Hemopurifier is a single use extracorporeal device that converges hollow-fiber filtration technology with immobilized affinity agents to capture viruses and soluble glycoproteins from the blood. The device has been designed to mimic the natural immune response of clearing infectious viruses and immunosuppressive proteins from circulation. Regulatory and commercialization initiatives in the United States are focused on bioterror threats, while international initiatives are directed towards naturally evolving pandemic threats, and chronic infectious disease conditions including Hepatitis-C (HCV) and the Human Immunodeficiency Virus (HIV). Collaborative studies to demonstrate utility of the Hemopurifier are being conducted with researchers at the Government of India's National Institute of Virology (NIV), The Centers for Disease Control and Prevention (CDC), The United States Army Medical Research Institute of Infectious Diseases (USAMRIID), and The Southwest Foundation for Biomedical Research (SFBR). Aethlon recently demonstrated safety of the Hemopurifier in a 24-treatment human study and is now conducting follow-on safety studies at the Fortis Hospital in Delhi, India. The Company has also submitted an Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) related to advancing the Hemopurifier as a broad-spectrum treatment countermeasure against category "A" bioterror threats. Additional information regarding Aethlon Medical and its Hemopurifier technology can be accessed online at www.aethlonmedical.com.

For more info: http://armd.realpennies.com

Aradigm Corporation (OTCBB: ARDM)is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment and prevention of severe respiratory diseases by pulmonologists. Current activities include partnered and self-initiated development programs addressing the treatment of cystic fibrosis, bronchiectasis, pulmonary hypertension, inhalation anthrax infections and smoking cessation. More information about Aradigm can be found at www.aradigm.com.

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

RealPennies .
Telephone: 1-800-940-6559
Matt /at/ realpennies.com